Table 1

Clinical and genetic features of female carriers with norrin cysteine knot growth factor mutations

IDAge range at examination (years)ExoncDNA changeProtein changeMutation typeReferenceBCVAFFA
ODOSODOS
N130s3c.362G>Ap.Arg121GlnMissenseReported20/2020/20BB
N220s3c.281A>Tp.His94LeuMissenseReported20/2020/20CC
N330s3c.334delp.Gly113AlafsFrameshiftReported20/2020/25AA
N420s3c.391T>Gp.Cys131GlyMissenseReported20/2020/20BB
N540s3c.338G>Ap.Gly113AspMissenseReported20/2020/20BB
N620s3c.391T>Gp.Cys131GlyMissenseReported20/2520/25AC
N720s3c.401G>Cp.*134SerStoplossNovel20/50020/125AA
N830s2whole gene deletionCNVReported20/2020/20CC
N920s2c.109C>Tp.Arg37*Non-senseReported20/2020/20BB
N1020s2c.109C>Tp.Arg37*Non-senseReported20/2020/20AA
N1130s2exon2 deletionCNVReported20/2020/20CA
N1220s3c.181C>Gp.Leu61ValMissenseNovel20/2520/25CC
  • A, typical FEVR phenotype; B, milder vascular abnormalities previously reported in familial exudative vitreoretinopathy patients; BCVA, best corrected visual acuity; C, normal vasculature; CNV, copy number variant; OD, right eye; OS, left eye.